The finding that Endo180-deficient CAFs in culture retain markers of fibroblast activation led us to test the hypothesis that the CAF contractility defect has a cell intrinsic effect on Endo180−/− fibroblast viability in the tumour stroma. The gene discussed is MRC2; the disease is neoplasm.